iSpecimen Inc. (ISPC) Current Ratio
- Current ratio · latest quarter: Value 0.82×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 0.82× | Current assets / current liabilities. $4.48M ÷ $5.48M ≈ 0.82× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 4.48M USD | Assets, Current |
| Current obligations | 5.48M USD | Liabilities, Current |
| Cash and equivalents | 4.41M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current · Debt Securities, Available-for-sale, Current |
| Customer receivables | 21.26K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | Inventory, Net |
| Payables | 4.67M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.48M | $5.48M | $4.41M | (m) | $21.26K | (m) | $4.67M | (m) | 0.82× |
| 2026-03-31 | $3.48M | $5.60M | $2.82M | (m) | $132.85K | (m) | $4.71M | (m) | 0.62× |
| 2025-12-31 | $6.95M | $6.23M | (m) | (m) | $48.30K | (m) | $5.36M | (m) | 1.12× |
| 2025-09-30 | $3.60M | $5.70M | (m) | (m) | $120.93K | (m) | $4.77M | (m) | 0.63× |
| 2025-06-30 | $1.17M | $5.17M | (m) | (m) | $372.47K | (m) | $4.32M | (m) | 0.23× |
| 2025-03-31 | $1.53M | $4.92M | (m) | (m) | $581.65K | (m) | $3.79M | (m) | 0.31× |
| 2024-12-31 | $3.59M | $5.77M | $1.88M | (m) | $1.44M | $45.11K | $4.20M | (m) | 0.62× |
| 2024-09-30 | $4.66M | $6.27M | $1.75M | $0.00 | $974.38K | (m) | $4.06M | (m) | 0.74× |
| 2024-06-30 | $5.24M | $5.81M | $2.15M | $0.00 | $892.81K | (m) | $4.21M | (m) | 0.90× |
| 2024-03-31 | $5.29M | $5.70M | $2.09M | $466.49K | $437.42K | (m) | $3.56M | (m) | 0.93× |
| 2023-12-31 | $8.24M | $6.05M | $2.34M | $2.66M | $728.39K | (m) | $3.93M | (m) | 1.36× |
| 2023-09-30 | $9.13M | $3.52M | $2.72M | $2.94M | $1.71M | (m) | $2.28M | (m) | 2.59× |
| 2023-06-30 | $10.97M | $2.86M | $2.00M | $6.21M | $1.46M | (m) | $1.78M | (m) | 3.84× |
| 2023-03-31 | $15.96M | $3.85M | $3.76M | $7.26M | $3.01M | (m) | $2.70M | (m) | 4.14× |
| 2022-12-31 | $19.68M | $4.28M | $15.31M | $0.00 | $1.60M | (m) | $2.46M | (m) | 4.60× |
| 2022-09-30 | $24.24M | $2.83M | $20.66M | (m) | $1.78M | (m) | $967.74K | (m) | 8.55× |
| 2022-06-30 | $27.13M | $2.03M | $23.69M | (m) | $1.66M | (m) | $433.03K | (m) | 13.37× |
| 2022-03-31 | $30.15M | $2.05M | $26.10M | (m) | $2.36M | (m) | $281.49K | (m) | 14.73× |
| 2021-12-31 | $32.95M | $2.51M | $27.74M | (m) | $3.00M | (m) | $832.68K | (m) | 13.15× |
| 2021-09-30 | $14.90M | $2.10M | $9.79M | (m) | $2.72M | (m) | $351.42K | (m) | 7.09× |
| 2021-06-30 | $16.92M | $5.93M | $13.18M | (m) | $1.99M | (m) | $3.23M | (m) | 2.86× |
| 2020-12-31 | $3.47M | $22.14M | $695.91K | (m) | $1.53M | (m) | $1.79M | (m) | 0.16× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |